Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1995; 73(04): 735-736
DOI: 10.1055/s-0038-1653857
DOI: 10.1055/s-0038-1653857
Letters to the Editor
Continuous Infusion of Prostacyclin Decreases Plasma Levels of t-PA and PAI-1 in Primary Pulmonary Hypertension
Further Information
Publication History
Received 30 August 1994
Accepted after resubmission 22 December 1994
Publication Date:
09 July 2018 (online)
-
References
- 1 Rubin LJ. Primary pulmonary hypertension. Chest 1993; 104: 236-250
- 2 Anglés-Cano E, Sultan Y, Clauvel J-P. Predisposing factors to thrombosis in systemic lupus erythematosus. Possible relation to endothelial cell damage J Lab Clin Med 1979; 94: 312-323
- 3 Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70-75
- 4 Higenbottam TW, Spiegelhalter D, Scott J-P, Fuster V, Dinh-Xuan AT, Caine N, Wallwork J. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J 1993; 70: 366-370
- 5 Anglés-Cano E, Grailhe P, Boyer-Neumann C, Brenot F, Peynaud-Debayle E, Azarian R, Simonneau G, Duroux P, Meyer D. Markers of endothelial involvement in chronic pulmonary hypertension. Fibrinolysis 1994; 8 suppl (Suppl. 01) 139 Abstr